Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 378 across all filing types
Latest filing 2024-01-31 Report Publication Anno…
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement regarding the scheduling of an Investor Relations (IR) meeting (Non-Deal Roadshow). It provides logistical details such as date, location, and purpose, but does not contain the actual presentation slides or detailed financial analysis. Under the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Regulatory Filing (RNS) when it does not fit into more specific categories like RPA (which is typically for report publication).
2024-01-31 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory announcement regarding the adjustment of the conversion price of convertible bonds (CB) for L&C Bio. It details the change in conversion price, the number of shares, and the underlying reason (market price decline). This type of filing is a standard capital structure update related to financing instruments, which falls under the 'Capital/Financing Update' category.
2023-12-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of an executive (Lee Whan-chul) of L&C Bio. This type of filing is a standard regulatory requirement for insider trading or changes in ownership by directors/major shareholders, which corresponds to the 'Director's Dealing' category.
2023-12-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership by the largest shareholder and related parties, including specific transaction dates, methods (gift, conversion), and share counts. This falls under the category of Major Shareholding Notification.
2023-12-29 Korean
자기주식처분결과보고서
Transaction in Own Shares Classification · 100% confidence The document is a '자기주식처분결과보고서' (Report on the Results of Disposal of Treasury Shares) filed by L&C Bio to the Financial Supervisory Service. It details the specific number of shares disposed of, the disposal price, and the date of the transaction. This falls under the category of a company reporting the sale or disposal of its own shares, which corresponds to the 'Transaction in Own Shares' (POS) category.
2023-12-22 Korean
주요사항보고서(자기주식처분결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the 'Decision to Dispose of Treasury Shares' (자기주식 처분 결정). This filing details the company's plan to transfer its own shares to an employee welfare fund. Since the document specifically reports the company's action regarding its own shares (disposal/buyback), it falls under the 'Transaction in Own Shares' category.
2023-12-21 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.